Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Resident parenchymal cells represent the primary functional cell types within an organ, such as hepatocytes in the liver, alveolar epithelial cells in the lungs, or cardiomyocytes in the heart (Britannica, 2023). These cells are distinguished from the stroma, which consists of connective tissue, blood vessels, and nerves that support the parenchyma. In the context of injured tissue, resident parenchymal cells are often the primary targets of damage, undergoing processes such as apoptosis, necrosis, or cellular senescence in response to inflammatory or toxic insults (Nature Reviews Molecular Cell Biology, 2020). While these cells are the ultimate site of action for many therapeutic interventions, they do not constitute a single molecular target; rather, they express a diverse array of receptors, enzymes, and ion channels that are targeted by drugs (NIH/NCBI, 2021). For instance, drugs may aim to prevent parenchymal cell death or stimulate the proliferation of resident progenitor cells to restore organ function. Consequently, understanding the specific molecular landscape of these cells in a diseased state is crucial for the development of targeted therapies that can promote tissue regeneration and limit the progression of chronic conditions like fibrosis (Journal of Clinical Investigation, 2018).
Not applicable; this term refers to a broad cell population across multiple organs rather than a specific molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Resident parenchymal cell.